bococizumab: Clinical Trials

4 trials of bococizumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow bococizumab: new trials by email Literature Review of bococizumab trials Research Report on bococizumab

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects
Bococizumab (PF-04950615;RN316), Placebo, Ezetimibe - Hypercholesterolemia
Phase 2CompletedPfizer2182014-03-012019-02-08
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
PBO, 200mg PF-04950615 (RN316), 300mg PF-04950615 (RN316) - Hypercholesterolemia
Phase 2CompletedPfizer3542012-07-012017-12-05
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
Placebo, Statin, PF-04950615 (RN316) - Hypercholesterolemia, Dyslipidemia
Phase 2CompletedPfizer932011-07-012017-10-11
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
Placebo, PF-04950615 (RN316) - Hypercholesterolemia, Dyslipidemia
Phase 2CompletedPfizer462011-06-012017-11-08

Conditions studied

Hypercholesterolemia (4)  ·  Dyslipidemias (2)

Sponsors

Pfizer (4)

Countries

United States (3)  ·  Canada (2)  ·  Japan (1)

Results publications

PMID 37994400, PMID 28181260, PMID 29037448, PMID 25784512, PMID 28539539, PMID 31549625